Clinical trials: Huntington's Disease (HD)
Huntington's Disease (HD), Exergame
Comparison of Two Cognitive-Motor Rehabilitation Approaches Via Exergames: a Study of Cognitive, Motor and Behavioral Functions in Huntington's Disease Patients
Huntington's disease (HD) is a rare, hereditary neurodegenerative disorder. It generally manifests itself between the ages of 40 and 50, and results in motor impairment (choreic movements, balance disorders, gait disorders…
- Trial name
- CARE-MH (NCT06807892)
- Testing
- Synergistic management, Sequential management
- Where
- France
- Volunteers
- 40 people
- Sponsor
- University Hospital, Angers
Huntington's Disease (HD)
Facilitating Effective Eating With DoddleBags: A Single-Arm Acceptability Study Of DoddleBags to Assess Impact on Self Feeding Behaviours in a Huntington's Disease Population
Primary Objectives To assess the acceptability of using the DoddleBags feeding aid in people with HD, by using a food diary to track food intake and using semi-structured interviews to ask questions about how easy or difficult it…
- Trial name
- FEEDhd (NCT07299682)
- Testing
- DoddleBags
- Where
- 7 sites in United Kingdom
- Sponsor
- University of Hull
Huntington's Disease (HD)
Social Cognition Training in Individuals With Huntington's Disease
Individuals with Huntington's Disease have impaired social cognition, which is the domain of cognition that allows individuals to understand others' perspectives so that they can navigate interpersonal actions successfully (e.g.…
- Trial name
- NCT06828471
- Testing
- Social Cognition Training
- Where
- United States
- Volunteers
- 20 people
- Sponsor
- Rush University Medical Center
Huntington Disease
The NAD-HD Study: A Study to Investigate Efficacy and Safety of Nicotinamide Riboside Compared With Placebo in Huntington's Disease
The goal of this clinical trial is to learn if oral supplement of nicotinamide riboside (NR), a form of vitamin B3, slows disease progression in adults with Huntington's disease.
- Trial name
- NAD-HD (NCT06853743)
- Testing
- Nicotinamide Riboside (NR)
- Where
- Norway
- Volunteers
- 120 people
- Sponsor
- Oslo University Hospital